| ［1］ |
Borghi A, Corazza M, Bertoldi AM, et al. Low⁃dose acitretin in treatment of plaque⁃type psoriasis: descriptive study of efficacy and safety［J］. Acta Derm Venereol, 2015, 95（3）: 332⁃336. DOI: 10.2340/00015555⁃1921.
|
| ［2］ |
Nast A, Gisondi P, Ormerod AD, et al. European S3⁃Guidelines on the systemic treatment of psoriasis vulgaris--Update 2015--Short version--EDF in cooperation with EADV and IPC［J］. J Eur Acad Dermatol Venereol, 2015, 29（12）: 2277⁃2294. DOI: 10.1111/jdv.13354.
|
| ［3］ |
中华医学会皮肤性病分会银屑病学组. 中国银屑病治疗专家共识（2014版）［J］. 中华皮肤科杂志, 2014, 47（3）: 213⁃215. DOI: 10.3760/cma.j.issn.0412⁃4030.2014.03.017.
|
| ［4］ |
Sarkar R, Chugh S, Garg VK. Acitretin in dermatology［J］. Indian J Dermatol Venereol Leprol, 2013, 79（6）: 759⁃771. DOI: 10.4103/0378⁃6323.120721.
|
| ［5］ |
Carretero G, Ribera M, Belinchón I, et al. Guidelines for the use of acitretin in psoriasis. Psoriasis Group of the Spanish Academy of Dermatology and Venereology［J］. Actas Dermosifiliogr, 2013, 104（7）: 598⁃616. DOI: 10.1016/j.adengl.2013.01.001.
|
| ［6］ |
孙建方, 温海, 郝飞, 等. 阿维A治疗寻常性银屑病120例［J］. 中华皮肤科杂志, 2008, 41（3）: 204⁃205. DOI: 10.3321/j.issn:0412⁃4030.2008.03.036.
|
| ［7］ |
冯素英, 林麟, 靳培英. 维A酸类药的临床应用、不良反应及对策［J］. 中华皮肤科杂志, 2003, 36（8）: 485⁃486.
|
| ［8］ |
冯素英, 林麟, 靳培英. 维A酸类药的临床应用、不良反应及对策［J］. 中华皮肤科杂志, 2003, 36（9）: 543⁃545.
|
| ［9］ |
Bonifati C, Lora V, Graceffa D, et al. Management of psoriasis patients with hepatitis B or hepatitis C virus infection［J］. World J Gastroenterol, 2016, 22（28）: 6444⁃6455. DOI: 10.3748/wjg.v22.i28.6444.
|
| ［10］ |
Di LV, Bonamonte D, Lasagni C, et al. Effectiveness and safety of acitretin in children with plaque psoriasis: a multicenter retrospective analysis［J］. Pediatr Dermatol, 2016, 33（5）: 530⁃535. DOI: 10.1111/pde.12940.
|
| ［11］ |
Piaserico S, Conti A, Lo CF, et al. Efficacy and safety of systemic treatments for psoriasis in elderly patients［J］. Acta Derm Venereol, 2014, 94（3）: 293⁃297. DOI: 10.2340/00015555⁃1719.
|
